Regulatory requirement for Medical Devices
Abstract
The safety and regulatory compliance of a widely used medical device have become a growing concern among a significant population. This has raised questions about the assessment of risks, monitoring of adverse drug reactions (ADR), and overall product safety. The efficacy and safety of such medical devices heavily rely on the regulations and guidelines set forth by regulatory agencies (RAs).
In the pharmaceutical industry, regulatory affairs (RA) professionals play a crucial role in overseeing the lifecycle of healthcare products. They provide strategic, tactical, and operational guidance to ensure compliance with regulations, facilitating the efficient development and delivery of safe and effective healthcare products worldwide. Evaluating adherence to regulations requires a combination of expertise from the business, legal, and pharmaceutical domains.
Regulatory authorities must thoroughly monitor medical device design, development, and manufacturing processes to guarantee that the products reaching the market are safe and effective. The certification process is intricate, involving multiple steps and the assessment of materials by competent authorities. In the United States, manufacturers must seek marketing authorization from the United States Food and Drug Administration (USFDA) through two primary application types: 510(k) and Pre-Market Application (PMA). In the European Union (EU), national authorities grant permission for the sale of medical devices, employing a third-party compliance system where notified bodies ensure quality assurance pre- and post-approval. In India, the Central Drug Standard Control Organization (CDSCO) licenses devices for sale and import under the CLAA framework.
Conclusion
Pharmaceutical regulatory affairs experts play a critical role in ensuring compliance with industry requirements for all pharmaceutical products. This review provides an overview of how medical devices are regulated and monitored in the EU, India, and the USA, emphasizing the importance of regulatory affairs in maintaining the safety and efficacy of healthcare products.
Downloads
References
https://www.who.int/publications/i/item/9789241512350
2. Pabbati S, Hira K, Begum AS. MEDICAL DEVICES AND THEIR APPROVAL PROCEDURE IN INDIA. Int J Drug Reg Affairs [Internet]. 2018 Feb.13 [cited 2023 Nov. 30];4(3):19-. Available from:
https://www.ijdra.com/index.php/journal/article/view/186
3. Rao NR, Tiwari A, Pal A, Pathak A, Maurya A, Ali I. Overview of drug regulatory affairs and role of regulatory affairs in a pharmaceutical industry.Pakistan Heart Journal. 2023 Jul 1;56(2):986-98.
4. Badjatya JK. OVERVIEW OF DRUG REGULATORY AFFAIRS AND REGULATORY PROFESSION. Int J Drug Reg Affairs [Internet]. 2013Feb.5 [cited 2023 Nov. 30];1(1):1-. Available from:
https://www.ijdra.com/index.php/journal/article/view/1
5. T Rao NR, Tiwari A, Pal A, Pathak A, Maurya A, Ali I. Overview of drug regulatory affairs and role of regulatory affairs in a pharmaceutical industry. Pakistan Heart Journal. 2023 Jul 1;56(2):986-98.
6. Force GH. Principles of in vitro diagnostic (IVD) medical devices classification. Global Harmonization Task Force; 2008.
7. Pisano DJ, Mantus D. FDA regulatory affairs: a guide for prescription drugs, medical devices, and biologics. CRC Press; 2004.
8. Moonsamy MR. correlation between tertiary education and pharmaceutical industry requirements for regulatory affairs pharmacists (doctoral dissertation) [Internet] WITS University; 2016 Jun [cited 2023 Nov 15]. Available from:
https://wiredspace.wits.ac.za/server/api/core/bitstreams/d0c01e31-aace-4366-b26e-9a22b2e78585/content
9. Hanuja GS, Kumari BS, Nagabhushanam MV, Reddy DN, Bonthagarala B. Regulatory requirements for registration of generic drugs in “BRICS” countries. International Journal of Pharmaceutical Science and Health Care. 2016 Nov:2249-5738
10. Rajan R, Bhasi AB. Open Innovation and IP Management in Medical Devices: A Review on Scope, Drivers and Barriers. Trends in Biomaterials & Artificial Organs. 2021 Jan 1;35(1).
11. Kumar S, Panwar R, Singh U. Regulatory affairs in the pharmacy curriculum. International Journal of Research and Development in Pharmacy and Life Sciences. 2013 Oct;2(6):690-8.
12. Basha SS, Shakeel SM, Nagabhushanam MV, Reddy DN, Bonthagarala B. The Assesment of Current Regulatory Guidelines for Biosimilars-A Global Scenario. World Journal of Pharmaceutical Research. 2016 Nov 9:2277-7105.
13. S.M.Shakeel, Shaik Salman Basha, M.V.Nagabhushanam, D.Nagarjuna Reddy, Brahmaiah Bonthagarala, Comparision of Regulatory Requirements for Generic Drugs Dossier Submission in United States and Canada, International Journal of Pharmaceutical Science and Health Care. 2017 Nov-Dec;6(6):1-19
14. Keutzer L, Simonsson US. Medical device apps: an introduction to regulatory affairs for developers. JMIR mHealth and uHealth. 2020 Jun 26;8(6):e17567.
15. Kramer DB, Tan YT, Sato C, Kesselheim AS. Ensuring medical device effectiveness and safety: a cross-national comparison of approaches to regulation. Food and drug law Journal. 2014;69(1):1.
16. Dragonetti M. From Directive 93/42/EEC to the new European (MDR) Medical Device Regulation: gap analysis and implementation for a software medical device.
17. Parvizi N, Woods K. Regulation of medicines and medical devices: contrasts and similarities. Clinical medicine. 2014 Feb;14(1):6
18. General Medical Council [Internet]. UK: General Medical Council; 2021 Apr 05 [cited on 2023 Nov 15] Available from:
www.gmc-uk.org/guidance
19. Medicines and Healthcare Products Regulatory Agency. Committee on the Safety of Devices [Internet]. MHRA; 2013 [cited on 2023 Nov 15] Available from:
www.mhra.gov.uk/Committees/Devices/CommitteeontheSafetyofDevices
20. World Health Organization. Clinical evidence for medical devices: regulatory processes focussing on Europe and the United States of America: background paper 3, August 2010 [Internet] World Health Organization; 2010 [cited 2023 Nov15]. Available from:
https://iris.who.int/handle/10665/70454?locale-attribute=en&locale=zh&mode=full
21. T. Sukanya, M. V. Nagabhushanam, Y. Ratna Sindhu, S. K. Sanjuda, R. Gnana Ramya, Brahmaiah Bonthagarala and G. Ramakrishna Branded/generic drugs: global issues and regulatory Controls. World Journal of Pharmaceutical Research. 2022 Jul 02;11(12):298-317. DOI: 10.20959/wjpr202212-25225
22. Pietzsch, J. B., Aquino, L. M., Yock, P. G., Paté-Cornell, M. E., and Linehan, J. H. (October 19, 2007). "Review of U.S. Medical Device Regulation." ASME. J. Med. Devices. December 2007; 1(4): 283–292.
https://doi.org/10.1115/1.2812429
23. Food and Drug Administration [Internet]. US FDA; 2023 [cited 2023 Nov15]. Available from:
http://www.fda.gov/cdrh/
24. Medicines and Healthcare Products Regulatory Agency. Committee on the Safety of Devices, [Internet] 2013. [cited on 2023 Nov 15]. Available from:
www.mhra.gov.uk/Committees/Devices/committeeonthesafetyofdevices
25. Kumar S, Panwar R, Singh U. Regulatory affairs in the pharmacy curriculum. International Journal of Research and Development in Pharmacy and Life Sciences. 2013 Oct;2(6):690-8.
26. Abu-Faraj ZO. Bi0engineering/Biomedical Engineering Education. Handbook of Research on Biomedical Engineering Education and Advanced Bioengineering Learning: Interdisciplinary Concepts: Interdisciplinary Concepts. 2012 Feb 29;2:1.
27. Porter R. Disease, medicine and society in England, 1550-1860. Cambridge University Press; 1995 Sep 14.
28. Shah AR, Goyal RK. Current status of the regulation for medical devices. Indian journal of pharmaceutical sciences. 2008 Nov;70(6):695.
29. Webster JG. Encyclopedia of medical devices and instrumentation. United States of America; 2006.
30. Das A, Kumar S. Innovation, IPR and Public Good. Express Pharma Pulse. 2008;3(7):16-31.
31. Srivastava D: A country level report on the pharmaceutical sector in India part one:Institutions involved in pharmaceutical regulation. LES Research; 2008.
32. Van Norman GA. Drugs, devices, and the FDA: part 2: an overview of approval processes: FDA approval of medical devices. JACC: Basic to Translational Science. 2016 Jun;1(4):277-87.
33. Fargen KM, Frei D, Fiorella D, McDougall CG, Myers PM, Hirsch JA, Mocco J. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation? Journal of neurointerventional surgery. 2013 Jul 1;5(4):269-75.
34. Yong C, Kaplan DS, Gray A, Ricles L, Kwilas A, Brubaker S, Arcidiacono J, Xu L, Chang C, Robinson R, McFarland R. Overview of the US Food and Drug Administration Regulatory Process. InPrinciples of Regenerative Medicine. Academic Press; 2019 Jan 1.p.1345-1365
35. Darrow JJ, Avorn J, Kesselheim AS. FDA regulation and approval of medical devices: 1976-2020. Jama. 2021 Aug 3;326(5):420-32.
36. Sweet BV, Schwemm AK, Parsons DM. Review of the processes for FDA oversight of drugs, medical devices, and combination products. Journal of Managed Care Pharmacy. 2011 Jan;17(1):40-50.
37. Monsein LH. Primer on medical device regulation. Part I. History and background. Radiology. 1997 Oct;205(1):1-9.
38. Jayanti VR, Madisi P, Murthy KVR. Requirements for introducing Medical devices in India and US market - A comparative study of regulations. Int J Drug Reg Affairs [Internet]. 2018 Dec.15 [cited 2023 Nov .30];6(4):9-20. Available from:
https://ijdra.com/index.php/journal/article/view/279
39. Maisel WH. Medical device regulation: an introduction for the practicing physician. Annals of internal medicine. 2004 Feb 17;140(4):296-302.
40. Howie SR, Hill SE, Peel D, Sanneh M, Njie M, Hill PC, Mulholland K, Adegbola RA. Beyond good intentions: lessons on equipment donation from an African hospital. Bulletin of the World Health Organization. 2008;86:52-6.
41. World Health Organization. Medical device donations: considerations for solicitation and provision [Internet]. Geneva, Switzerland: World Health Organization, 2011 [cited 2023 Nov 15]. Available from:
https://asprtracie.hhs.gov/technical-resources/resource/12195/medical-device-donations-considerations-for-solicitation-and-provision
42. World Health Organization [Internet]. Geneva, Switzerland: World Health Organization, 2023 [cited 2023 Nov 15]. Available from:
http://www.who.org/
43. Wilson B. If It's Reusable Why not Reuse It-The Reuse of Single use Medical Devices. Dalhousie LJ. 2011;34:229.
44. Howie SR, Hill SE, Peel D, Sanneh M, Njie M, Hill PC, Mulholland K, Adegbola RA. Beyond good intentions: lessons on equipment donation from an African hospital. Bulletin of the World Health Organization. 2008;86:52-6
45. Gatrad AR, Gatrad S, Gatrad A. Equipment donation to developing countries. Anaesthesia. 2007;62(1):90–95
doi/10.1111 j.1365-2044.2007.05309.x/pdf
46. Marks IH, Thomas H, Bakhet M, Fitzgerald E. Medical equipment donation in low-resource settings: a review of the literature and guidelines for surgery and anaesthesia in low-income and middle-income countries. BMJ Glob Health. 2019 Sep 29;4(5):e001785.
doi: 10.1136/bmjgh-2019-001785.
47. The British Standards Institution [Internet].UK: The British Standards Institution; 2023 [cited 2023 Nov 15]. Available from:
https://www.bsigroup.com/
48. World Health Organisation [Internet]. WHO Technical Report Series, No. 1003, 2017, Geneva, Switzerland from 18 April 2016: World Health Organisation, 2017 [cited 2023 Nov 15]. Available from:
https://cdn.who.in
49. Hailey D, Jacobs PD, Ries NM, Polisena J. Reuse of single use medical devices in Canada: clinical and economic outcomes, legal and ethical issues, and current hospital practice. International journal of technology assessment in health care. 2008 Oct;24(4):430-6.
50. Tessarolo F, Disertori M, Caola I, Guarrera GM, Favaretti C, Nollo G. Health technology assessment on reprocessing single-use catheters for cardiac electrophysiology: results of a three-years study. In2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2007 Aug 22.p.1758-1761.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
